Allogene Therapeutics ALLO
NASDAQ ALLO
$1.25 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Cash & Current Investments (2018 - 2026)

Updated

Allogene Therapeutics (ALLO) recorded Cash & Current Investments of $332.6 million in Q2 2026, up 21.8% from $273.12 million a year earlier and up 24.6% from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Allogene Therapeutics reported Cash & Current Investments of $250.21 million, down 14.5% from FY2024.

  • Annual Cash & Current Investments has declined for three straight years, with a five-year compound annual growth rate of -21.3% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $292.48 million in FY2024 (-34.8%), $448.7 million in FY2023 (-13.3%), $517.32 million in FY2022 (+13.1%) and $457.3 million in FY2021 (-44.8%).
  • The Q2 2026 figure is the highest quarterly Cash & Current Investments since Q2 2024.
  • On a year-over-year basis, Cash & Current Investments rose in 1 of the last eight quarters, with an average decline of 18.6%.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 21.8% in Q2 2026, against a decline of 44.8% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $266.89 million (Q1 2026), $250.21 million (Q4 2025) and $252.19 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Allogene Therapeutics 431.68 Mn -670.21 Mn - 332.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 332.60 Mn
Mar 31, 2026 266.89 Mn
Dec 31, 2025 250.21 Mn
Sep 30, 2025 252.19 Mn
Jun 30, 2025 273.12 Mn
Mar 31, 2025 280.04 Mn
Dec 31, 2024 292.48 Mn
Sep 30, 2024 291.56 Mn
Jun 30, 2024 444.63 Mn
Mar 31, 2024 384.86 Mn
Dec 31, 2023 448.70 Mn
Sep 30, 2023 465.51 Mn
Jun 30, 2023 491.96 Mn
Mar 31, 2023 471.22 Mn
Dec 31, 2022 517.32 Mn
Sep 30, 2022 552.23 Mn
Jun 30, 2022 490.49 Mn
Mar 31, 2022 449.05 Mn
Dec 31, 2021 457.30 Mn
Sep 30, 2021 483.49 Mn
API Access

Allogene Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ALLO&period=max&api_key=YOUR_API_KEY